 | Haloperidol | IC50 | 4.0 [1] |
| Haloperidol | Ki | 1.8 [1] |
 | 1,3-Di-o-tolylguanidine | IC50 | 31.0 [1] |
| 1,3-Di-o-tolylguanidine | Ki | 28.8 [1] |
 | (+)-Pentazocine | Ki | 2.1 [1], 2.7 [2], 3.77 [3], 6.1 [4], 152.0 [5] |
 | alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol | IC50 | 71.0 [1], 83.0 [2], 112.0 [3], 120.0 [4] |
| alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol | Ki | 71.0 [1], 164.0 [2], 265.0 [3] |
 | N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine | Ki | 0.7 [1] |
 | Nalorphine | IC50 | 735.0 [1] |
 | Rimcazole | IC50 | 450.0 [1], 588.84 [2], 780.0 [3], 1400.0 [4], 1480.0 [5] |
| Rimcazole | Ki | 680.0 [1], 820.0 [2], 908.0 [3] |
 | Phencyclidine | IC50 | 560.0 [1], 868.0 [2], 1000.0 [3], 1050.0 [4] |
| Phencyclidine | Ki | 1090.0 [1], 1767.0 [2] |
 | 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine | Ki | 5.3 [1] |
 | S1RA | Ki | 17.0 [1] |
 | Pentazocine | Ki | 36.5 [1], 83.1 [2], 110.0 [3] |
 | (S)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol | IC50 | 140.0 [1], 213.8 [2], 310.0 [3], 420.0 [4] |
| (S)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol | Ki | 490.0 [1] |
 | (R)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol | IC50 | 28.0 [1], 32.0 [2], 43.0 [3], 436.52 [4] |
| (R)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol | Ki | 64.0 [1] |
 | Buspirone | IC50 | 36.31 [1], 263.0 [2] |
| Buspirone | Ki | 212.0 [1], 2427.0 [2] |
 | 1,3-Diphenylguanidine | IC50 | 397.0 [1], 400.0 [2] |
| 1,3-Diphenylguanidine | Ki | 713.0 [1] |
 | Siramesine | Ki | 17.0 [1] |
 | N,N'-Bis(4-methylphenyl)guanidine | IC50 | 535.0 [1] |
| N,N'-Bis(4-methylphenyl)guanidine | Ki | 3.1 [1], 164.0 [2] |
 | (10As)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione | IC50 | 3.9 [1], 650.0 [2] |
| (10As)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione | Ki | 4.5 [1] |
 | ((R)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine | Ki | 17.0 [1], 21.8 [2], 28.0 [3], 39.0 [4] |
 | Naloxone | IC50 | 100000.0 [1] |
| Naloxone | Ki | 100000.0 [1] |
 | Apomorphine | IC50 | 10000.0 [1], 31000.0 [2] |
 | Vanoxerine | IC50 | 1.0 [1], 43.0 [2] |
| Vanoxerine | Ki | 318.0 [1] |
 | Fenpropimorph | Ki | 0.01 [1], 0.08 [2], 17.3 [3] |
 | [2-(3,4-Dichloro-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-cyclohexyl)-amine | Ki | 1.3 [1], 7.78 [2] |
 | (-)-cis-(1S,2R)-U-50488 Tartrate | IC50 | 194.0 [1] |
| (-)-cis-(1S,2R)-U-50488 Tartrate | Ki | 118.0 [1], 221.0 [2] |
 | 5-Bromo-N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2,3-dimethoxybenzamide | Ki | 12900.0 [1] |
 | N-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-methoxy-5-methylbenzamide | Ki | 3078.0 [1] |
 | (1S,13R)-1,13-Dimethyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | Ki | 124.0 [1], 150.0 [2], 169.0 [3] |
 | (+)-[2-(3,4-Dichloro-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-cyclohexyl)-amine | Ki | 6.0 [1], 18.68 [2] |
 | ((S)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine | Ki | 10.8 [1], 22.0 [2] |
 | 3-Chloro-6-methylamino-8-phenyl-5,6,7,8-tetrahydro-naphthalen-2-ol | IC50 | 10.47 [1], 21.1 [2], 10000.0 [3] |
 | (10Ar)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione | IC50 | 1000.0 [1] |
| (10Ar)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione | Ki | 7.1 [1] |
 | Unii-G7fms28pyd | IC50 | 285.0 [1] |
| Unii-G7fms28pyd | Ki | 232.0 [1] |
 | 1,2-Bis(3-methylphenyl)guanidine | IC50 | 43.0 [1], 59.0 [2], 84.0 [3] |
 | Guanidine, N,N'-bis(3-ethylphenyl)- | IC50 | 8.0 [1], 8.3 [2], 30.0 [3] |
 | Methyl-((S)-1-methyl-2-phenyl-ethyl)-phenethyl-amine | Ki | 4.8 [1], 6.6 [2], 16.4 [3] |
 | ((R)-1-Methyl-2-phenyl-ethyl)-phenethyl-amine | Ki | 13.6 [1], 60.0 [2], 61.0 [3] |
 | N,N''-Bis(2-ethylphenyl)guanidine | IC50 | 13.8 [1], 14.0 [2], 44.0 [3] |
 | 1,3-Bis(4-bromophenyl)guanidine | IC50 | 33.0 [1], 350.0 [2], 540.0 [3] |
 | N,N'-Bis(2-methoxyphenyl)guanidine | IC50 | 1990.0 [1], 2200.0 [2], 3800.0 [3] |
 | (9S,13S)-10-Benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | Ki | 0.67 [1], 1710.0 [2] |
 | (1R,13S)-1,13-Dimethyl-10-pentyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | Ki | 0.29 [1], 3.8 [2], 10.5 [3] |
 | 1,2-Bis(2-iodophenyl)guanidine | IC50 | 13.0 [1], 14.0 [2], 16.0 [3] |
 | 2,2-Dimethyl-N-[1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]propanamide | Ki | 51.0 [1], 51.29 [2] |
 | [1-(4-Methoxy-3-phenethyloxy-benzyl)-4-methyl-pentyl]-propyl-amine; hydrochloride | IC50 | 1.8 [1], 200.0 [2], 210.0 [3] |
 | Progesterone | Ki | 260.0 [1], 1284.0 [2] |
 | Morphine | Ki | 10000.0 [1], 100000.0 [2] |
 | Tamoxifen | Ki | 8.71 [1], 35.0 [2] |
 | Fluoxetine | IC50 | 851.14 [1] |
| Fluoxetine | Ki | 210.0 [1] |
 | Clozapine | Ki | 8500.0 [1] |
 | Amiodarone | Ki | 1.0 [1], 41.0 [2] |
 | Dizocilpine | IC50 | 10000.0 [1] |
 | Sertraline | Ki | 29.3 [1], 57.0 [2] |
 | Raloxifene | Ki | 38.0 [1], 286.0 [2] |
 | Sulpiride | IC50 | 10000.0 [1] |
 | Clomiphene | Ki | 8.0 [1], 12.0 [2] |
 | trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide | Ki | 696.0 [1], 1270.0 [2] |
 | Proadifen | IC50 | 1584.89 [1] |
| Proadifen | Ki | 17.0 [1] |
 | Astemizole | Ki | 944.0 [1], 1258.93 [2] |
 | Clemastine | Ki | 10.0 [1], 14.0 [2] |
 | 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-allyl-6,11-dimethyl- | Ki | 59.7 [1], 429.0 [2] |
 | 3-(1-Propyl-3-piperidinyl)phenol | IC50 | 76.0 [1] |
| 3-(1-Propyl-3-piperidinyl)phenol | Ki | 78.5 [1] |
 | Buflomedil | Ki | 912.2 [1], 1290.0 [2] |
 | Tenocyclidine | IC50 | 1100.0 [1], 2060.0 [2] |
 | (-)-Vesamicol | Ki | 26.0 [1] |
 | 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine | IC50 | 17.0 [1] |
 | Caramiphen | Ki | 15.5 [1], 26.0 [2] |
 | NE 100 hydrochloride | IC50 | 1.3 [1], 85.0 [2] |
 | Polyhexamethyleneguanidine | IC50 | 750.0 [1], 800.0 [2] |
 | 1-[2-(3,4-Dichlorophenyl)ethyl]-4-methylpiperazine | Ki | 6.3 [1], 9.2 [2] |
 | Reduced haloperidol | Ki | 14.34 [1] |
 | Aptiganel | IC50 | 2535.0 [1], 2540.0 [2] |
 | 4-Phenyl-1-(4-phenylbutyl)piperidine | Ki | 0.8 [1], 1.0 [2] |
 | Naluzotan | Ki | 100.0 [1], 2000.0 [2] |
 | 1'-Benzyl-1-methoxyspiro[1H-2-benzofuran-3,4'-piperidine] | Ki | 1.14 [1] |
 | 1'-Benzyl-3-methoxyspiro[isochroman-1,4'-piperidine] | Ki | 1.29 [1] |
 | 1,4-Dibenzylpiperazine | Ki | 5.81 [1] |
 | sigma-LIGAND-1 | IC50 | 36.0 [1], 43.0 [2] |
 | 13-Methyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | Ki | 3600.0 [1], 4300.0 [2] |
 | 1-Benzyl-4-(4-methoxybenzyl)piperazine | Ki | 0.47 [1] |
 | Spipethiane | Ki | 0.5 [1], 0.59 [2] |
Calculator
